Effects of cisplatin and other Pt(II) complexes on spontaneous motility of isolated human oviduct

Toxicology in Vitro

Volumn 22, Issue 8, 2008, Pages 1878-1882

  Bugarčić, Živadin D ^a   Petrović, Biljana ^a   Bugarčić, Zorica M ^a   Janković, Slobodan M ^a   Janković, Snežana V ^a   Lukić, Goran ^a   Novaković, Milan ^a   Kostović, Vladimir ^a   Popović, Suzana ^a   Djurdjević, Predrag ^a   Baskić, Dejan ^a   Arsenijević, Nebojša ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

Author keywords

Cytotoxicity; Human fallopian tubes; Platinum(II)

Indexed keywords

CISPLATIN; DICHLORO(S METHYL LEVO CYSTEINE)PLATINUM II; DICHLOROBIS(DIMETHYLSULFOXIDE)PLATINUM II; DIMETHYL SULFOXIDE; PLATINUM COMPLEX; S METHYLCYSTEINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL MOTILITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OVIDUCT; PERIPHERAL BLOOD MONONUCLEAR CELL; SENSITIVITY ANALYSIS; UTERINE TUBE;

ADULT; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; CYSTEINE; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FALLOPIAN TUBES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH;

EID: 55249120397     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.09.011     Document Type: Article

References (21)

1. Bogdanović G., Kojić V., Srdić T., Jakimov D., Djuran M.I., Bugarčić Z.D., Baltić M., and Baltić V.V. Growth effects of some platinum(II) complexes with sulfur-containing carrier ligands on MCF7 human breast cancer cell line upon simultaneous administration with Taxol. Metal-Based Drugs 9 (2002) 33-43
2. Bowman W.C., and Rand M.J. Principles of drug action. In: Bowman W.C., and Rand M.J. (Eds). Textbook of Pharmacology (1980), Blackwell Scientific Publication, Oxford 1-46
3. 2O. Dalton Transition (2004) 279-286
4. Chvetzoff G., Bonotte B., and Chauffert B. Anticancer chemotherapy. Prevention of toxicity. Presse Medicale 27 (1998) 2106-2112
5. Ekerhovd E., Brannstrom M., Weijdegard B., and Norstrom A. Localization of nitric oxide synthase and effects of nitric oxide donors on the human fallopian tube. Molecular Human Reproduction 5 (1999) 1040-1047
6. Esposito B.P., and Najjar R. Interactions of antitumoral platinum-group metallodrugs with albumin. Coordination Chemical Reviews 232 (2002) 137-149
7. Fuertes M.A., Alonso C., and Pérez J.M. Biochemical modulation of cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chemistry Reviews 103 (2003) 645-662
8. Jakubec M.A., Galanski M., and Keppler B.K. Tumour-inhibiting platinum complexes-state of the art and future perspectives. Reviews of Physiology Biochemistry and Pharmacology 149 (2003) 1-53
9. Jamieson E.R., and Lippard S.J. Structure, recognition, and processing of cisplatin-DNA adducts. Chemical Reviews 99 (1999) 2467-2498
10. Kenakin T.P. The classification of drugs and drug receptors in isolated tissues. Pharmacological Reviews 36 (1984) 165-222
11. In: Lippert B. (Ed). Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug (1999), Wiley-VCH, Zürich 183-221
12. Magnus R. Versuche am überlebenden dunndarm von säugetieren. I. Mittheilung Pflugers Archive 102 (1904) 123-151
13. Perez Martinez S., Viggiano M., Franchi A.M., Herrero M.B., Ortiz M.E., Gimeno M.F., and Villalon M. Effect of nitric oxide synthase inhibitors on ovum transport and oviductal smooth muscle activity in the rat oviduct. Journal of Reprodaction and Fertiity 118 (2000) 111-117
14. Petrović D., Stojimirović B., Petrović B., Bugarčić Z.M., and Bugarčić Z.D. Studies of interactions between platinum(II) complexes and some biologically relevant molecules. Bioorganic and Medicinal Chemistry 15 (2007) 4203-4211
15. Reedijk J. Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell. Chemical Reviews 99 (1999) 2499-2510
16. Soldatović T., and Bugarčić Z.D. Study of the reactions between platinum(II) complexes and l-methionine in the presence and absence of 5′-GMP. Journal of Inorganic Biochemistry 99 (2005) 1472-1479
17. Tangir J., Zelterman D., Ma W., and Schwartz P.E. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstetretics and Gynecoly 101 (2003) 251-257
18. Tangjitgamol S., See H.E., Manusirivithaya S., Levenback C.F., Gershenson D.M., and Kavanagh J.J. Third-line chemotherapy in platinum- and paclitaxel-resistant ovarian, fallopian tube, and primary peritoneal carcinoma patients. International Journal of Gynecolological Cancer 14 (2004) 804-814
19. 2+ model adducts. Inorganic Chemistry 38 (1999) 1450-1455
20. Wang D., and Lippard S.J. Cellular processing of platinum anticancer drugs. Nature Reviews: Drug Discovery 4 (2005) 307-320
21. Wong E., and Giandomenico C.M. Current status of platinum-based antitumor drugs. Chemical Reviews 99 (1999) 2451-2466